Authors’ reply to ‘Reply to EC de Haas and HJ Luijendijk, Eur J Intern Med. 2019 Apr; 62: e8-e9’ by S Portsmouth et al.

In response to our comment, Dr Portsmouth and colleagues provide additional information about the results of the CAPSTONE-1 trial [1], which we appreciate. In our comment, we underlined that the composition of the study population should have been taken into account when the study results were analysed, interpreted and presented.